There are challenges in the use of glutathione as a diagnostic biomarker and therapeutic target
Dosage: In human sleep studies, researchers have used intravenous doses of 25nmol per kilogram.13 14 Intravenous administration boasts higher bioavailability than, say, the subcutaneous route,28 which is the more common mode of administration for peptides, so a home-use case would likely involve a higher dose
The rest of the co-authors critically revised and corrected the final version of the manuscript
However, in these studies, most LAAS were strokes due to extracranial atherosclerosis (ECAS), while it is unclear whether the findings are applicable in strokes due intracranial atherosclerosis (ICAS)
The compound is inexpensive enough to study on its own, and the GLOW Blend can be added to a subsequent research phase without discarding prior work